None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female over 18 years old 2. Those who want to perform upper gastrointestinal endoscopy 3. Patients who voluntarily signed written consent
Exclusion criteria
Exclusion criteria: 1. Patients who are deemed inappropriate to participate in this clinical study under the researcher's judgment for other serious diseases or disorders 2. Patients who are unable to understand and comply with consent (eg, mental deficiency, illiteracy, etc.) 3. Patients with a DNA extraction concentration of 50ng/ul or less
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The association of 2143G and 2182C mutation of 23S rRNA of Helicobacter pylori with the eradication failure in clarithromycin-based triple therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| The eradication success rate of 2nd line regimen in patients of treatment failure with 1st line clarithromycin-based triple therapy of H. pylori | — |
Countries
Korea, Republic of
Contacts
Daegu Fatima Hospital